Many readers may be interested in an article on active surveillance and other forms of expectant management by Khurana and Stephenson that appears on the front page of the November issue of the AUA News. This article is based on a poster presented by Khurana et al. at the annual meeting of the American Urological Association earlier this year.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: active surveillance, expectant management, observation, watchful waiting |
Though interesting, the study has many weaknesses that preclude any meaningful conclusions at this time, including:
(1) The median ages were widely different (80 vs. 64 years)
(2) The median follow-up was less than 4 years.
(3) Less than 10% of the two groups have died.
(4) Less than 8% have been followed more than 10 years.